2019 National Drug & Alcohol Facts Week® (NDAFW): January 22-27
NIDA: NDAFW is a week-long series of events that links teens to science-based facts to shatter the myths about drugs. Healthcare professionals can participate in NDAFW by providing teens with free resources about drugs. For other event ideas, toolkits, and to register your event, go to the National Drug and Alcohol Facts Week webpage.
Discover how OUD affects the brain and how evidence-based treatments are saving lives
Airing 9 p.m., Wednesday, Oct. 17. Program Description: Hear firsthand from individuals struggling with addiction and follow the cutting-edge work of doctors and scientists as they investigate why addiction is not a moral failing, but a chronic, treatable medical condition. Learn More
Barriers Rural Physicians Face Prescribing Buprenorphine for Opioid Use Disorder
A national study surveyed all rural physicians who have received a waiver in the United States and found that those who were not actively prescribing buprenorphine reported significantly more barriers than those who were. View the Abstract
STR-TA Requests Coming in Strong, Communities Working to Address the Opioid Overdose Crisis
The first few months of the State Targeted Response Technical Assistance (STR-TA) initiative provide insight into how much help is needed in local communities on the prevention, treatment and recovery of opioid use disorder. As a result, states and territories are responding to the STR-TA request center for innovative approaches to meet the need with […]
Opioid Prescribing to Adolescents in the United States From 2005 to 2016
Between 2005 and 2016, opioid prescriptions for adolescents generally were written for longer than three days, and the number of prescriptions filled for four and five day supplies increased, according to study by the American Psychiatry Association. Read Abstract
The State of Opioid Medication Assisted Treatment (MAT)
Despite efforts to increase availability of medication assisted treatment at the federal level, drug overdoses, particularly those of the opioid category, remain the leading cause of death in Americans younger than 50 years of age. Most of these involve synthetic opioids with a 540% increase in related deaths in the past 3 years… View full […]
Pennsylvania Hospital Becomes OUD Treatment Model After Working with PCSS During Pilot Program
Hanover Hospital and its affiliated healthcare clinics has become a model for how a healthcare system that is fully engaged in embracing evidence-based treatment of opioid use disorders can make significant change. A little more than a year ago, PCSS reached out to Hanover Hospital to participate in a five-state pilot program to create a […]
AAP Challenges Pediatric Surgeons to Cut Opioid Prescriptions at Discharge in Half
In March, the American Academy of Pediatrics (AAP) Section on Surgery’s Executive Committee issued a six-month challenge to pediatric surgeons to decrease opioid prescribing by 50% at discharge. Not long ago, writing a prescription for opioids was routine practice following surgery, says Vivian Thorne, Manager, Division of Hospital and Surgical Services at AAP. With rising […]
2017 HHS Accomplishments on Opioids
Marking the end of the first year of the Trump Administration, the U.S. Department of Health and Human Services (HHS) released a report highlighting accomplishments from 2017. “In 2017, HHS took bold action to advance its mission to protect and enhance the health and well-being of the American people. From a newly aggressive approach to […]
FDA approves first once-monthly buprenorphine injection, a medication-assisted treatment option for opioid use disorder
The U.S. Food and Drug Administration today approved Sublocade, the first once-monthly injectable buprenorphine product for the treatment of moderate-to-severe opioid use disorder (OUD) in adult patients who have initiated treatment with a transmucosal (absorbed through mucus membrane) buprenorphine-containing product. It is indicated for patients that have been on a stable dose of buprenorphine treatment […]
